Abstract:Abstract Background Current methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning and related neural networking methods have state-of-the-art performance, their vulnerability in decision making processes leading to irrational outcomes is a major concern for their implementation. With the rising antibiotic resistance, antimicrobial peptides (AMPs) have increasingly gained attention as novel therapeutic agents. This challenging design problem requires peptides which meet the multiple constraints of limiting drug-resistance in bacteria, preventing secondary infections from imbalanced microbial flora, and avoiding immune system suppression. AMPs offer a promising, bioinspired design space to targeting antimicrobial activity, but their versatility also requires the curated selection from a combinatorial sequence space. This space is too large for brute-force methods or currently known rational design approaches outside of machine learning. While there has been progress in using the design space to more effectively target AMP activity, a widely applicable approach has been elusive. The lack of transparency in machine learning has limited the advancement of scientific knowledge of how AMPs are related among each other, and the lack of general applicability for fully rational approaches has limited a broader understanding of the design space. Methods Here we combined an evolutionary method with rough set theory, a transparent machine learning approach, for designing antimicrobial peptides (AMPs). Our method achieves the customization of AMPs using supervised learning boundaries. Our system employs in vitro bacterial assays to measure fitness, codon-representation of peptides to gain flexibility of sequence selection in DNA-space with a genetic algorithm and machine learning to further accelerate the process. Results We use supervised machine learning and a genetic algorithm to find a peptide active against S. epidermidis , a common bacterial strain for implant infections, with an improved aggregation propensity average for an improved ease of synthesis. Conclusions Our results demonstrate that AMP design can be customized to maintain activity and simplify production. To our knowledge, this is the first time when codon-based genetic algorithms combined with rough set theory methods is used for computational search on peptide sequences.

A Multi-Property Optimizing Generative Adversarial Network for de novo Antimicrobial Peptide Design

AMPGAN v2: Machine Learning-Guided Design of Antimicrobial Peptides

Multi-CGAN: Deep Generative Model-Based Multiproperty Antimicrobial Peptide Design

Intelligent De Novo Design of Novel Antimicrobial Peptides against Antibiotic-Resistant Bacteria Strains

A generative artificial intelligence approach for antibiotic optimization

De novo synthetic antimicrobial peptide design with a recurrent neural network

De novo multi-mechanism antimicrobial peptide design via multimodal deep learning

Designing antimicrobial peptides using deep learning and molecular dynamic simulations

Exploring the Repository Ofde Novodesigned Bifunctional Antimicrobial Peptides Through Deep Learning

MOFormer: Multi-Objective Antimicrobial Peptide Generation Through Conditional Transformer with Multi-Fusion Descriptors

Evolutionary Multi-Objective Optimization in Searching for Various Antimicrobial Peptides [Feature]

De Novo Antimicrobial Peptide Design with Feedback Generative Adversarial Networks

A foundation model approach to guide antimicrobial peptide design in the era of artificial intelligence driven scientific discovery

ProT-Diff: A Modularized and Efficient Approach to De Novo Generation of Antimicrobial Peptide Sequences through Integration of Protein Language Model and Diffusion Model

Combining genetic algorithm with machine learning strategies for designing potent antimicrobial peptides

MoFormer: Multi-objective Antimicrobial Peptide Generation Based on Conditional Transformer Joint Multi-modal Fusion Descriptor

Application of a deep generative model produces novel and diverse functional peptides against microbial resistance

dsAMP and dsAMPGAN: Deep Learning Networks for Antimicrobial Peptides Recognition and Generation

Machine Learning Accelerates De Novo Design of Antimicrobial Peptides

Accelerating Antimicrobial Discovery with Controllable Deep Generative Models and Molecular Dynamics

Exploring the repository of designed bifunctional antimicrobial peptides through deep learning